- Home
- IVD
- By Technology Types
- By Diseases Types
- By Product Types
- Research
- Resource
- Distributors
- Company
| Product Name | Calsenilos (KCNIP3) Antibody |
| Catalog No. | NSMA-0054 |
| Description | Calsenilos (DREAM) interacts with presenilins and regulates calcium signaling. This antibody is used to study pain modulation and Alzheimer's disease pathology. |
| Host Species | Mouse |
| Isotype | IgG1 |
| Specificity | Human KCNIP3 |
| Immunogen | Recombinant human KCNIP3 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purity | Protein G Purified |
| Concentration | 1.0 mg/mL |
| Buffer | PBS, pH 7.2 |
| Preservative | 0.01% Sodium Azide |
| Stability | 18 months |
| Storage | -20°C |
| Applications | IHC, WB, ELISA |
| Reactivity | Human, Mouse |
| Molecular Weight | 29 kDa |
| Sensitivity | High |
| Cross-Reactivity | Specific to KCNIP3 |
| Background Staining | Low |
| Clonality | Monoclonal |
| Usage Level | Research/IVD Grade |
| Shipping Condition | Blue Ice |
| Solubility | Aqueous |
| Biological Activity | Ca2+ binding active |
| Target System | Presenilin Signaling |
For research use only, not for clinical use.
|
There is no product in your cart. |